Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 338.50
Bid: 335.50
Ask: 337.50
Change: -3.50 (-1.02%)
Spread: 2.00 (0.596%)
Open: 355.00
High: 355.00
Low: 335.00
Prev. Close: 342.00
VLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update

18 Apr 2024 07:00

RNS Number : 0447L
Volex PLC
18 April 2024
 

 

18 April 2024

 

Volex plc

 

("Volex" or the "Group")

Full Year Trading Update

Further diversification and strong growth

Volex (AIM: VLX), the specialist integrated manufacturer of critical power and data transmission products, today releases a trading update for the financial year ended 31 March 2024.

Full year performance ahead of market expectations

Revenue is now expected to be at least $900 million, representing an increase of at least 25% over the prior year, including seven months contribution from the acquisition of Murat Ticaret, while underlying operating profit1 is also now anticipated to be slightly ahead of analyst expectations2.

This performance underscores Volex's ability to secure additional customer commitments and deliver new projects, whilst maintaining robust financial and operational discipline.

Operating profit margins improved in the second half of the year. This was partly a result of product mix, including the contribution of Off-Highway sales, offset by accelerating investment in future strategic growth initiatives to support increased, long-term customer demand.

Strong organic growth driven by attractive positions in diversified end-markets

The second half of the year saw continuing increases in organic revenue, a result of leading positions in attractive, diversified end-markets that possess structural growth characteristics. Exposure to a number of growth sectors, provides the Board with confidence in the Group's ability to make strategic progress even in volatile market conditions. The acquisition of Murat Ticaret also delivered significant incremental revenue, in a largely new end-market.

The Medical and Complex Industrial Technology sectors delivered extremely strong growth, partly due to pent-up demand arising from previous global supply chain challenges, as well as increased sales of high-speed data centre cables. Off-Highway operations achieved high growth in addition to the incremental contribution from the acquisition of Murat Ticaret.

Performance in both Electric Vehicles and Consumer Electricals improved in the second half of the year. Although revenues in these sectors remain below FY2023 levels, a reduction in the amount of customer destocking experienced in the second half creates confidence in the potential for a return to growth in the forthcoming financial year.

Continuing to invest in profitable growth opportunities

The Group's presence in attractive markets and its well-invested global manufacturing base offer significant growth opportunities. Strategic investment initiatives continued throughout the year to support customer requirements and will continue during FY2025.

In response to increasing customer demand, the Group invested in the further expansion of its global manufacturing base, creating additional capacity to facilitate growth as part of the Group's five-year growth plans which target revenues of $1.2 billion by the end of FY2027.

The integration of Murat Ticaret is progressing according to plan, with continuing positive engagement from customers and staff alike. The integration activities will accelerate in FY2025, including stepping up the investment programme in North America to replicate the success of the Off-Highway operations in Europe.

The cash generative nature of the business provides the Group with flexibility over internal growth investment and M&A activity. Cash flow was very strong in the second half of the year, with covenant leverage at the year end expected to be approximately 1.1x.

Nat Rothschild, Executive Chairman, said: "Our ability to continue to deliver strong growth in challenging markets is a testament to the quality of the team, our strategy and our ability to respond to the needs of our customers. We enter the new financial year with confidence and optimism thanks to the strong momentum generated in the current financial year, improving market conditions in the Electric Vehicles and Consumer Electricals sectors, as well as an abundance of opportunities in the new Off-Highway sector. Our continued, strategic investment initiatives will support increased customer demand as we continue to make strong progress towards the delivery of our five-year plan."

 

For further information please contact:

Volex plc

+44 (0)7747 488 785

Nat Rothschild, Executive Chairman

Jon Boaden, Chief Financial Officer

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

Ed Allsopp / Ben Harrington

HSBC Bank plc (Joint Broker)

+44 (0)20 7991 8888

Simon Alexander / Joe Weaving

Powerscourt

+44 (0)20 7250 1446

James White / Nicholas Johnson

 

 

About Volex plc

Volex plc (AIM:VLX) is a driving force in integrated manufacturing for mission-critical applications and a global leader in power and data connectivity solutions. Our diverse operations support international blue-chip customers in five key sectors: Electric Vehicles, Consumer Electricals, Medical, Complex Industrial Technology and Off-Highway. Headquartered in the UK, we orchestrate operations across 28 advanced manufacturing facilities, uniting over 12,000 dynamic individuals from 24 different nations. Our extraordinary products find their way to market through our localised sales teams and authorised distributor partners, supporting Original Equipment Manufacturers and Electronic Manufacturing Services companies across the globe. In a world that grows more digitally complex by the day, customers trust us to deliver power and connectivity that drives everything from household essentials to life-saving medical equipment. Learn more at www.volex.com.

 

Notes

1. Underlying operating profit is before adjusting items which are one-off in nature and significant (such as restructuring costs, impairment charges or acquisition-related costs), the amortisation and impairment of acquired intangible assets and share-based payment charges. This trading update is based upon unaudited management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. The Company has compiled forecasts from five analysts with current market forecasts for the 52 weeks ended 31 March 2024 for revenue to be in the range of $849.8 million to $873.0 million, with a consensus of $859.5 million, and for underlying operating profit to be in the range of $83.3 million to $84.6 million, with a consensus of $84.2 million.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFWFWWELSEIL
Date   Source Headline
3rd Oct 20083:56 pmRNSHolding(s) in Company
3rd Oct 20083:20 pmRNSBlocklisting Interim Review
3rd Oct 20083:14 pmRNSBlocklisting Interim Review
22nd Sep 20087:00 amRNSStrategic Review and Trading Update
13th Aug 20081:05 pmRNSAnnual Information Update
6th Aug 20083:52 pmRNSHolding(s) in Company
6th Aug 20083:46 pmRNSHolding(s) in Company
6th Aug 200811:13 amRNSHolding(s) in Company
24th Jul 200812:05 pmRNSResult of AGM
23rd Jul 20087:00 amRNSAGM & Interim Management Stat
11th Jul 20083:23 pmRNSDirector/PDMR Shareholding
11th Jul 20083:21 pmRNSDirector/PDMR Shareholding
11th Jul 20083:19 pmRNSDirector/PDMR Shareholding
2nd Jul 200811:02 amRNSHolding(s) in Company
9th Jun 20087:00 amRNSFinal Results
28th May 200810:16 amRNSNotice of Results
27th May 20087:00 amRNSDirectorate Change
1st May 20089:50 amRNSHolding(s) in Company
18th Apr 20081:00 pmRNSHolding(s) in Company
17th Apr 20084:29 pmRNSHolding(s) in Company
10th Apr 200811:53 amRNSBlocklisting Interim Review
10th Apr 200811:40 amRNSBlocklisting Interim Review
1st Apr 200812:09 pmRNSHolding(s) in Company
13th Mar 200811:42 amRNSHolding(s) in Company
10th Mar 20087:44 amRNSTrading Statement
3rd Mar 20089:48 amRNSHolding(s) in Company
18th Feb 20083:09 pmRNSDirector/PDMR Shareholding
15th Feb 20087:00 amRNSInterim Management Statement
1st Feb 20083:12 pmRNSHolding(s) in Company
29th Jan 20083:59 pmRNSTrading Update
24th Jan 200812:57 pmRNSDirectorate Change
23rd Jan 20085:02 pmRNSDirectorate Change
10th Jan 200812:30 pmRNSDirectorate Change
19th Dec 20073:26 pmRNSHolding(s) in Company
6th Dec 200711:16 amRNSHolding(s) in Company
12th Nov 20077:00 amRNSInterim Results
1st Nov 20073:36 pmRNSHolding(s) in Company
31st Oct 20071:51 pmRNSHolding(s) in Company
17th Oct 20074:49 pmRNSBlocklisting Interim Review
17th Oct 20074:48 pmRNSBlocklisting Interim Review
17th Oct 20074:48 pmRNSBlocklisting Interim Review
5th Oct 200712:10 pmRNSHolding(s) in Company
26th Sep 20073:25 pmRNSDirector/PDMR Shareholding
24th Sep 20079:41 amRNSHolding(s) in Company
24th Sep 20079:24 amRNSNotice of Results
28th Aug 200711:27 amRNSHolding(s) in Company
17th Aug 20073:12 pmRNSHolding(s) in Company
13th Aug 200711:03 amRNSAnnual Information Update
2nd Aug 200710:22 amRNSDirector/PDMR Shareholding
24th Jul 20074:29 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.